AIC-CCMB aims to supports not just startups’ and innovators using Information Communication Technology (ICT) in healthcare through its MSH centre but other incubators as well. CSIR -CCMB is a globally renowned research institution working in the field human health and genomics and is poised to take up a leadership role in precision medicine. AIC-CCMB aims to leverage this strength and foster innovation in the areas of Machine Learning, Artificial Intelligence, IoT, Blockchain, Robotics etc in healthcare and related emerging areas to address societal challenges in ICTE areas.
Application for Technology Incubation and Development of Entrepreneurs Scheme (TIDE 2.0)
Technology is meant to enhance the quality of life, and this is especially true in healthcare. The integration of cutting-edge technologies such as Artificial Intelligence, the Internet of Things, Data Analytics, Quantum Computing, Robotics, and Blockchain has significantly accelerated advancements in medical technology. These innovations enable medical professionals to diagnose and treat diseases more effectively. According to a report by Accenture, AI has the potential to contribute USD 957 billion to the Indian economy by 2035, boost India’s annual growth rate of gross value added (GVA) by 1.3 percentage points, and increase the country’s income by 15 percent (MEA, GOI). Despite these advancements, much remains to be explored, and the potential for further value addition across the healthcare value chain is vast.
The Atal Incubation Centre – Centre for Cellular & Molecular Biology (AIC-CCMB) invites early-stage tech startups to apply for financial and technical support under the Technology Incubation and Development of Entrepreneurs Scheme (TIDE 2.0) of the Ministry of Electronics and Information Technology (MeitY), Government of India.
The AIC-CCMB MeitY TIDE 2.0 Ideathon 5.0 aims to identify and select startups that utilize emerging technologies to address gaps in healthcare. Established at CSIR-CCMB, AIC-CCMB promotes the commercialization of life-saving products and services through startups in life sciences. By providing comprehensive support from ideation to industrialization and leveraging emerging technologies, AIC-CCMB helps startups bring their products and processes to market more efficiently and effectively. This support is crucial for fostering innovation and driving progress in the life sciences industry.
Areas of Focus
Under the MeitY TIDE 2.0 program, AIC-CCMB will support individual innovators or startups utilizing ICT and other emerging technologies in the following life sciences and healthcare areas:
1. Medical Devices: Point of care screening, monitoring, and diagnostics.
2. Systems Biology for Human Health & Disease: Drug Mechanism of Action, Predictive Modeling, Precision Medicine, Risk Assessment, Virtual Clinical Trials
3. Multimodal LLM-based Healthcare Innovation: Advanced Diagnostics and Health Informatics combining various medical datasets.
Join us in our mission to transform healthcare through innovation. Apply now to be part of the AIC-CCMB MeitY TIDE 2.0 program and significantly impact the future of healthcare.
For Entrepreneur In Residence:
For Grant in Aid:
The grant support cannot, however, be used for supporting:
